Billy Lynn, MD
Plastic and Reconstructive Surgery · Augusta, GANPI 1629050174
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 52.2% of the total. That places this record below the midpoint for plastic and reconstructive surgery clinicians in GA, where the typical reported total is $2,884.
Across 36 payments — averaging $38.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$720
- Sientra, Inc.$197
- Davol Inc.$147
- Mentor Worldwide LLC$133
- TELA Bio, Inc.$71
- Organogenesis Inc.$33
- plus $79 from 4 others
What the payments were for
- Food & beverage$1,380100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $720 |
| Sientra, Inc. | 2 | $197 |
| Davol Inc. | 1 | $147 |
| Mentor Worldwide LLC | 5 | $133 |
| TELA Bio, Inc. | 1 | $71 |
| Organogenesis Inc. | 1 | $33 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Kerecis Limited | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,380 in reported general payments places this provider in the 45th percentile of 83 plastic and reconstructive surgery providers in Georgia.
See all plastic and reconstructive surgery providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 67 | $487 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 47 | $278 |
| Levofloxacin | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Augusta
- Rajiv SoodAugusta$502K
- Christopher EwartAugusta$8K
- Sma Zaheed HassanAugusta$6K
- Trevor HansenAugusta$4K
- Piotr SkowronskiAugusta$1K
- George DrewAugusta$902
- Carmen KavaliAtlanta$233K
- Randal RuddermanAlpharetta$207K
- James NamnoumAtlanta$97K
- Michael MirzabeigiAtlanta$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.